Bramble Bio is a cutting-edge biotechnology CDMO company dedicated to advancing the field of advanced therapies through innovative research, development and manufacturing. Specializing in the development of cell and gene therapies, Bramble Bio focuses on harnessing the power of cellular therapies, gene editing, and tissue engineering to create groundbreaking treatments for a wide range of diseases and conditions for our clients. With a strong emphasis on collaboration and partnership, Bramble Bio works closely with leading researchers, clinicians, and industry partners to accelerate the translation of scientific discoveries into commercialized therapies that have the potential to transform patient care. By combining scientific expertise with a commitment to excellence, Bramble Bio is at the forefront of the advanced therapies revolution, striving to bring life-changing therapies to market and improve the lives of patients around the world. we'd be delighted to meet at Hub Xchanges Advanced Therapies event for you to learn more about our innovative way of working and partnership opportunities.